HYPERFINE INC (HYPR) Fundamental Analysis & Valuation

NASDAQ:HYPR • US44916K1060

Current stock price

1.29 USD
-0.02 (-1.53%)
At close:
1.29 USD
0 (0%)
After Hours:

This HYPR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HYPR Profitability Analysis

1.1 Basic Checks

  • In the past year HYPR has reported negative net income.
  • HYPR had a negative operating cash flow in the past year.
  • In the past 5 years HYPR always reported negative net income.
  • In the past 5 years HYPR always reported negative operating cash flow.
HYPR Yearly Net Income VS EBIT VS OCF VS FCFHYPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -64.37%, HYPR is doing worse than 73.26% of the companies in the same industry.
  • HYPR has a worse Return On Equity (-86.76%) than 62.03% of its industry peers.
Industry RankSector Rank
ROA -64.37%
ROE -86.76%
ROIC N/A
ROA(3y)-60.16%
ROA(5y)-53.42%
ROE(3y)-74.07%
ROE(5y)-63.23%
ROIC(3y)N/A
ROIC(5y)N/A
HYPR Yearly ROA, ROE, ROICHYPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • With a Gross Margin value of 49.79%, HYPR perfoms like the industry average, outperforming 45.99% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HYPR has grown nicely.
  • The Profit Margin and Operating Margin are not available for HYPR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y55.23%
GM growth 5YN/A
HYPR Yearly Profit, Operating, Gross MarginsHYPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. HYPR Health Analysis

2.1 Basic Checks

  • HYPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for HYPR has been increased compared to 1 year ago.
  • The number of shares outstanding for HYPR has been increased compared to 5 years ago.
  • There is no outstanding debt for HYPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HYPR Yearly Shares OutstandingHYPR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
HYPR Yearly Total Debt VS Total AssetsHYPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -4.13, we must say that HYPR is in the distress zone and has some risk of bankruptcy.
  • HYPR has a worse Altman-Z score (-4.13) than 70.59% of its industry peers.
  • There is no outstanding debt for HYPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.13
ROIC/WACCN/A
WACC8.9%
HYPR Yearly LT Debt VS Equity VS FCFHYPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • HYPR has a Current Ratio of 4.34. This indicates that HYPR is financially healthy and has no problem in meeting its short term obligations.
  • HYPR's Current ratio of 4.34 is fine compared to the rest of the industry. HYPR outperforms 69.52% of its industry peers.
  • HYPR has a Quick Ratio of 3.73. This indicates that HYPR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.73, HYPR is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 3.73
HYPR Yearly Current Assets VS Current LiabilitesHYPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. HYPR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.00% over the past year.
  • The Revenue has been growing slightly by 5.22% in the past year.
  • Measured over the past years, HYPR shows a very strong growth in Revenue. The Revenue has been growing by 115.18% on average per year.
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
Revenue 1Y (TTM)5.22%
Revenue growth 3Y25.79%
Revenue growth 5Y115.18%
Sales Q2Q%128.05%

3.2 Future

  • HYPR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.69% yearly.
  • HYPR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.73% yearly.
EPS Next Y16.21%
EPS Next 2Y9.48%
EPS Next 3Y5.5%
EPS Next 5Y6.69%
Revenue Next Year49.7%
Revenue Next 2Y39.35%
Revenue Next 3Y21.98%
Revenue Next 5Y21.73%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HYPR Yearly Revenue VS EstimatesHYPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5M 10M 15M 20M 25M
HYPR Yearly EPS VS EstimatesHYPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. HYPR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HYPR. In the last year negative earnings were reported.
  • Also next year HYPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HYPR Price Earnings VS Forward Price EarningsHYPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYPR Per share dataHYPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.48%
EPS Next 3Y5.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HYPR Dividend Analysis

5.1 Amount

  • HYPR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HYPR Fundamentals: All Metrics, Ratios and Statistics

HYPERFINE INC

NASDAQ:HYPR (4/20/2026, 8:06:43 PM)

After market: 1.29 0 (0%)

1.29

-0.02 (-1.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-18
Earnings (Next)05-07
Inst Owners16.72%
Inst Owner Change-0.37%
Ins Owners1.36%
Ins Owner Change31.99%
Market Cap127.09M
Revenue(TTM)13.56M
Net Income(TTM)-35.57M
Analysts82.5
Price Target2.09 (62.02%)
Short Float %1.72%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.01%
Min EPS beat(2)-2.71%
Max EPS beat(2)38.73%
EPS beat(4)2
Avg EPS beat(4)5.29%
Min EPS beat(4)-16.81%
Max EPS beat(4)38.73%
EPS beat(8)5
Avg EPS beat(8)3.73%
EPS beat(12)8
Avg EPS beat(12)3.24%
EPS beat(16)10
Avg EPS beat(16)0.19%
Revenue beat(2)1
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-2.61%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-9.85%
Min Revenue beat(4)-25.57%
Max Revenue beat(4)0.67%
Revenue beat(8)4
Avg Revenue beat(8)-5.04%
Revenue beat(12)5
Avg Revenue beat(12)-6.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)24.24%
PT rev (3m)24.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)1.43%
EPS NY rev (3m)1.43%
Revenue NQ rev (1m)3.23%
Revenue NQ rev (3m)3.23%
Revenue NY rev (1m)11.36%
Revenue NY rev (3m)11.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.37
P/FCF N/A
P/OCF N/A
P/B 3.1
P/tB 3.1
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.14
BVpS0.42
TBVpS0.42
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -64.37%
ROE -86.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.79%
FCFM N/A
ROA(3y)-60.16%
ROA(5y)-53.42%
ROE(3y)-74.07%
ROE(5y)-63.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y55.23%
GM growth 5YN/A
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 108.72%
Cap/Sales 8.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.34
Quick Ratio 3.73
Altman-Z -4.13
F-Score5
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)74.32%
Cap/Depr(5y)130.8%
Cap/Sales(3y)6.33%
Cap/Sales(5y)41.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
EPS Next Y16.21%
EPS Next 2Y9.48%
EPS Next 3Y5.5%
EPS Next 5Y6.69%
Revenue 1Y (TTM)5.22%
Revenue growth 3Y25.79%
Revenue growth 5Y115.18%
Sales Q2Q%128.05%
Revenue Next Year49.7%
Revenue Next 2Y39.35%
Revenue Next 3Y21.98%
Revenue Next 5Y21.73%
EBIT growth 1Y14.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.91%
OCF growth 3YN/A
OCF growth 5YN/A

HYPERFINE INC / HYPR Fundamental Analysis FAQ

What is the fundamental rating for HYPR stock?

ChartMill assigns a fundamental rating of 3 / 10 to HYPR.


What is the valuation status of HYPERFINE INC (HYPR) stock?

ChartMill assigns a valuation rating of 0 / 10 to HYPERFINE INC (HYPR). This can be considered as Overvalued.


Can you provide the profitability details for HYPERFINE INC?

HYPERFINE INC (HYPR) has a profitability rating of 1 / 10.


Can you provide the financial health for HYPR stock?

The financial health rating of HYPERFINE INC (HYPR) is 6 / 10.